Resources from the 2022 NeuroAbilities Virtual Symposium

About the Symposium: 

As neurotechnologies (NT), including Brain-Computer Interfaces (BCI), evolve rapidly, what are their pathways to marketable solutions for Persons with Disabilities? What is their market potential? How can their design and applications best serve Persons with Disabilities?  How can barriers to adoption be lifted and neuroethics challenges resolved?

The 2022 NeuroAbilities Virtual Symposium explored these issues with experts from different stakeholder groups, featuring keynote presentations from the U.S. Food and Drug Administration, industry leaders, end users, advocates, and funders.  The two main pathways for BCI and NT devices development -- as regulated medical devices or unregulated direct-to-consumer (DTC) products – and their specific challenges and opportunities were featured over the course of the Symposium, held from March 30 - April 1, 2022.

Lists of Resource Links Shared by Panelists at the Symposium:

The following lists are compiled from panel sessions over the three (3) days of our Symposium, held from March 30, 2022 - April 1, 2022. For session recordings, please visit our NeuroAbilities YouTube Channel

Social Media:

Day 1: March 30, 2022

Theme: The Neurotech Opportunity for Persons with Disabilities

Day 2: March 31, 2022

Theme: Regulatory Frameworks & Alternative Paths for Direct-to-Consumer Technologies

Day 3: April 1, 2022

Theme: Disability Rights & Neuroethics